Cardiovascular Medicine for the MCCQE Part I: Chest Pain to Anticoagulation

Weight and scope

Eighteen questions is about 25 minutes of your 320. The domain looks large because the topics are familiar, but the questions reward precision on a small number of decision points: which patient needs immediate reperfusion, which needs anticoagulation, which needs a rate or rhythm strategy, and what blood pressure level changes management. Cardiovascular stems also appear in emergency, endocrine, pregnancy and geriatric questions, so the real exposure is higher than the count suggests.

The MCC publishes no discipline weights. The 8% figure is our editorial estimate from the MCC Examination Objectives and clinical presentations, and the count is rounded because some items in each section are unscored. Questions from this domain are also spread across the four dimensions of care and the four physician activities.

What is tested

• Acute coronary syndrome. Recognizing STEMI and NSTEMI from the history and ECG, immediate treatment, reperfusion decisions and secondary prevention after discharge.
• Heart failure. Reduced versus preserved ejection fraction, acute pulmonary edema, long-term drug classes and what to monitor.
• Hypertension. Diagnosis by office, home and ambulatory readings, treatment thresholds, drug choice in special populations and secondary causes.
• Rhythm disorders. Atrial fibrillation (rate or rhythm control and stroke prevention), supraventricular and ventricular tachycardia, bradyarrhythmias, heart block and pacemaker indications.
• Structural and inflammatory disease. Valve lesions, infective endocarditis, cardiomyopathy, myocarditis, pericarditis, tamponade and aortic dissection.
• Vascular disease. Peripheral arterial disease, acute limb ischemia, abdominal aortic aneurysm and DVT with anticoagulant choice.
• Risk and symptoms. Dyslipidemia and risk assessment, syncope, orthostatic hypotension and adult congenital heart disease.

Canadian points to anchor your answers

• Hypertension Canada. Diagnosis uses automated office BP of 135/85 or higher, manual office BP of 140/90 or higher (130/80 in diabetes), home mean of 135/85 or higher, or 24-hour ambulatory mean of 130/80 or higher. A reading of 180/110 or higher follows a faster pathway. The cited PDF is the 2018 edition, so confirm current wording for targets.
• First-line drugs. For uncomplicated hypertension, a thiazide-like diuretic, ACE inhibitor, ARB or long-acting calcium channel blocker, usually in a single-pill combination. Beta-blockers are not first line at 60 and older. RAS inhibitors are contraindicated in pregnancy.
• Special populations. Diabetes with albuminuria or cardiovascular disease favours an ACE inhibitor or ARB. After stroke or TIA, an ACE inhibitor with a thiazide-like diuretic. After MI, a beta-blocker with an ACE inhibitor. In heart failure, an ACE inhibitor or ARB with a beta-blocker.
• Canadian Cardiovascular Society. Lipid, atrial fibrillation and heart failure guidelines are the usual Canadian anchors. This page does not set out their thresholds, so take them from the source.
• Screening. The task force screening recommendation for abdominal aortic aneurysm is dated 2017. Check the current direction on the task force site.
• Names and units. Use epinephrine, norepinephrine, furosemide and ASA. Lipids are in mmol/L and troponin units follow the stem.

How the questions are framed

Cardiovascular stems usually give you an age, a risk factor profile, a few observations and one test result, often an ECG description or a troponin. The question then asks for the most likely diagnosis or the next best step. The answer often depends on one fact that moves the patient into a different pathway: hypotension, ongoing pain, a new murmur, a contraindication to an anticoagulant or a pregnancy. Read for that fact before you read the options.

Management questions favour the safe first action over the definitive one. Stabilize, monitor, give the immediate drug, then arrange the test. Communication items in this domain are typically about explaining a new diagnosis, discussing anticoagulation risk, shared decisions on screening, or lifestyle counselling after an event. Professional-behaviour items are less frequent but include driving restrictions and reporting.

Three typical traps

1. Treating a blood pressure number without the method. The same value means different things on automated office, manual, home and ambulatory measurement. Check which method the stem gives and which threshold applies.
2. Choosing the wrong drug class for the special population. Pregnancy rules out RAS inhibitors, and a patient with diabetes and albuminuria is steered to an ACE inhibitor or ARB. Check the comorbidity before the drug.
3. Ordering a test before stabilizing. In an unstable patient with a suspected acute coronary syndrome, dissection or tamponade, the correct step is usually resuscitation and a bedside action, not imaging that moves the patient away from monitoring.

How to revise it

1. Build one-page pathways for ACS, acute heart failure, new atrial fibrillation and suspected PE. Add the first drug, the first test and the escalation point.
2. Memorize the Canadian blood pressure thresholds by measurement method, and the drug-by-comorbidity table.
3. Drill ECGs for ten minutes a day: ischemia, hyperkalemia, QT prolongation, blocks and tachyarrhythmias.
4. Review anticoagulation as a prescribing topic. Learn indications, contraindications, monitoring and reversal from the current Canadian source.
5. Finish with mixed blocks of 20 to 40 questions that include emergency and endocrine stems, since the topics overlap.

Pair this domain with the emergency and critical care, endocrine and renal and population health pages, and see the Canadian guidelines guide.

Subtopic checklist

Our blueprint lists these 18 subtopics for this domain. Tick each one only when you can state the presentation, the first investigation and the first management step without notes.

• Acute coronary syndrome: STEMI and NSTEMI management
• Stable angina, chest pain assessment and secondary prevention
• Heart failure with reduced and preserved ejection fraction: drug therapy
• Acute pulmonary edema
• Hypertension: diagnosis, thresholds and drug choice
• Atrial fibrillation: rate and rhythm control and anticoagulation
• Supraventricular and ventricular tachyarrhythmias
• Bradyarrhythmias, heart block and pacemaker indications
• ECG interpretation (ischemia, hyperkalemia, QT prolongation)
• Valvular heart disease and infective endocarditis
• Cardiomyopathies, myocarditis and pericarditis
• Cardiac tamponade and aortic dissection
• Peripheral arterial disease and acute limb ischemia
• Abdominal aortic aneurysm
• Venous thromboembolism: DVT diagnosis and anticoagulant choice
• Dyslipidemia and cardiovascular risk assessment
• Syncope and orthostatic hypotension
• Congenital heart disease in adults

How the four dimensions of care show up

Every question in this domain is classified under one dimension of care, so revise cardiovascular in four ways, not one.

• Health promotion and illness prevention. Prevention: blood pressure and lipid screening, risk assessment, smoking cessation and secondary prevention after an event.
• Acute care. Acute: chest pain, acute pulmonary edema, new arrhythmia, aortic dissection and limb ischemia.
• Chronic care. Chronic: heart failure drug titration, hypertension follow-up, anticoagulation monitoring and valve surveillance.
• Psychosocial aspects. Psychosocial: adherence, cost of medication, depression after myocardial infarction and driving restrictions.

When you review a wrong answer, note which dimension the question belonged to as well as the topic. A pattern, such as repeated errors on the prevention items, tells you more than a topic score.